An acute and continuation phase study of the comparative efficacy of venlafaxine ER (Effexor XR) and fluoxetine (Prozac) in achieving and sustaining remission (wellness) in patients with recurrent unipolar major depression; followed by a long term randomized, placebo-controlled maintenance treatment study in patients treated initially with venlafaxine ER
Latest Information Update: 22 Oct 2015
At a glance
- Drugs Venlafaxine (Primary) ; Fluoxetine
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms PREVENT
- 01 Sep 2015 Results of post hoc analysis presented at the 28th Annual Congress of the European College of Neuropsychopharmacology
- 18 Aug 2009 Actual initiation date (1 Aug 2000) added as reported by ClinicalTrials.gov.
- 18 Aug 2009 Actual end date (1 Oct 2005) added as reported by ClinicalTrials.gov.